Depression, Epinephrine, and Platelet Function

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

January 31, 2009

Study Completion Date

January 31, 2009

Conditions
Major Depressive Disorder
Interventions
DRUG

Escitalopram

10 mg of Escitalopram, and titrated up to 20 mg of Escitalopram after day 22 of intervention

DRUG

Desipramine

25 mg of Desipramine for day 1-3, 50 mg of Desipramine for day 4-7, 75 mg of Desipramine for day 8-14, 100 mg of Desipramine for day 15-21. Titrated between 125 mg to 200 mg of Desipramine for day 22-56 of intervention

Trial Locations (1)

30322

Emory University School of Medicine, Atlanta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Emory University

OTHER

NCT00166114 - Depression, Epinephrine, and Platelet Function | Biotech Hunter | Biotech Hunter